PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

MD Tokens to trade on Knovatech OTC platform in Hong Kong

With the encouraging response from the early investors in Singapore and Hong Kong, MD Tokens is expanding its community of users across Asia

The mission of MD Tokens (MDTK) is to make healthcare really simple. It has started a digital platform that integrates all aspects of healthcare into one easy-to-use solution. It connects patients to doctors, pharmacies, insurers and laboratories.
After MD Tokens hit its soft-cap of 30mil tokens upon its launch in Hong Kong, there is lot of promise on the blockchain development within the healthcare space in Asia.
With the encouraging response from the early investors in Singapore and Hong Kong, MD Tokens is expanding its community of users across Asia.
With its sight on the larger markets of the Philippines, Indonesia, and India, and current overwhelming demand, MD Tokens is looking to be accessible for the regional users to acquire MDTK, via over counter trading facilities (OTC) and exchanges. This strategy roadmap is fast unfolding with its launch on Knovatech OTC platform.
The mechanism of trading on OTC platforms is increasingly the preferred mechanism for cryptocurrencies as security measures on holding the assets in cold wallets and away from cybersecurity threats is an attractive proposition.
The healthcare industry is booming in Asia and the cashless and secure transactions with MDTK are seen to be a first of its kind and have captured the attention of the investors.
With past healthcare ICOs that have lead to early stage digital health development, the promise of using MDTK immediately with an existing platform, MyDoc (www.my-doc.com), and development of its own mobile app wallet infrastructure to manage rewards in the healthcare space, is an exciting proposition to scale the digital health ecosystem.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026